Abiomed (NASDAQ: ABMD) is a manufacturer of medical implant devices, including the AbioCor artificial heart and Impella. It is headquartered in Danvers, Massachusetts and has an additional office in Aachen, Germany. It has 800 employees worldwide. Michael R. Minogue joined Abiomed in 2004, and serves as CEO, Chairman and President. For fiscal year 2016, Abiomed reported $329.5 million in revenue, $65.1 million in operating income, $38.1 million in net income, $423 million in total assets, and $369 million in equity.

Property Value
dbo:abstract
  • Abiomed es una empresa estadounidense con sede en Massachusetts fundada el 1981 que se dedica a la biotecnología y que tiene más de 300 empleados. Es por ejemplo la creadora del AbioCor. (es)
  • Abiomed (NASDAQ: ABMD) is a manufacturer of medical implant devices, including the AbioCor artificial heart and Impella. It is headquartered in Danvers, Massachusetts and has an additional office in Aachen, Germany. It has 800 employees worldwide. Michael R. Minogue joined Abiomed in 2004, and serves as CEO, Chairman and President. For fiscal year 2016, Abiomed reported $329.5 million in revenue, $65.1 million in operating income, $38.1 million in net income, $423 million in total assets, and $369 million in equity. (en)
dbo:assets
  • 4.23E8
dbo:equity
  • 3.69E8
dbo:foundingYear
  • 1981-01-01 (xsd:date)
dbo:keyPerson
dbo:location
dbo:netIncome
  • 3.81E7
dbo:numberOfEmployees
  • 800 (xsd:integer)
dbo:operatingIncome
  • 6.51E7
dbo:product
dbo:revenue
  • 3.295E8
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 6872689 (xsd:integer)
dbo:wikiPageRevisionID
  • 735847613 (xsd:integer)
dbp:industry
  • Medical Devices
dbp:logo
dbp:slogan
  • Recovering hearts. Saving lives.
dct:subject
http://purl.org/linguistics/gold/hypernym
rdf:type
rdfs:comment
  • Abiomed es una empresa estadounidense con sede en Massachusetts fundada el 1981 que se dedica a la biotecnología y que tiene más de 300 empleados. Es por ejemplo la creadora del AbioCor. (es)
  • Abiomed (NASDAQ: ABMD) is a manufacturer of medical implant devices, including the AbioCor artificial heart and Impella. It is headquartered in Danvers, Massachusetts and has an additional office in Aachen, Germany. It has 800 employees worldwide. Michael R. Minogue joined Abiomed in 2004, and serves as CEO, Chairman and President. For fiscal year 2016, Abiomed reported $329.5 million in revenue, $65.1 million in operating income, $38.1 million in net income, $423 million in total assets, and $369 million in equity. (en)
rdfs:label
  • Abiomed (es)
  • Abiomed (en)
owl:sameAs
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Abiomed Inc. (en)
is dbo:board of
is dbo:wikiPageRedirects of
is foaf:primaryTopic of